Redx Pharma is a drug discovery and development company formed in 2010. It is focused on improving the characteristics of existing drug classes to create new drugs in the areas of cancer, immunology and infection. The company's work has been endorsed by partnerships with global pharmaceutical companies and the NHS.

Find out more

Latest News

Final Results for the year ended 30 September 2016
21 March 2017

Redx (AIM: REDX) announces its results for the year ended 30 September 2016:

  • Discovery engine delivers two assets to progress into clinical stage from extensive pipeline
  • Strategic refocus — Redx restructures to become a research and development focused company
  • £12 million gross raised post the period end and £10 million gross raised in March 2016

Read more

In The Media

21 Mar 2017
Redx Pharma to refocus on key assets

10 Feb 2017
Cash influx will help Redx develop promising pre-clinical drug candidates

09 Feb 2017
Redx Pharma unveils plans to raise up to £14.9mln…